Freemodel helps homeowners capture the full value of their homes when they sell. Every year in the US, home flippers rake in $12 billion dollars of profit on the backs of homeowners who sell their properties for less than they’re worth. This happens because homeowners often lack the knowledge, skill, and money required to execute home renovations that maximize the value of their homes. Freemodel solves this by identifying the remodel scope that will maximize the value and appeal of the home, streamlining the bid process through a contractor marketplace, financing the project, and overseeing the entire renovation process. Sellers don’t pay Freemodel until they sell the home. Freemodel’s powerful Renovation Management Platform simplifies and streamlines every phase of the project, for the homeowner, agent, and contractor. Freemodel. Sell your home for more.

Inflammatix, Inc. is a venture-backed startup located in the San Francisco Bay Area that is building novel diagnostics for acute infections and sepsis based on our unique immune biomarkers. Approximately $10 billion / year is spent trying to diagnose acute infections, but current technologies that focus on ￃﾢ￢ﾂﾬￋﾜfinding the bugￃﾢ￢ﾂﾬ￢ﾄﾢ are (1) slow and (2) effective in fewer than 30% of cases. Inflammatixￃﾂￂﾠhas developed a statistically rigorous,ￃﾂￂﾠextensively validated diagnostic method that 'reads' the immune system. Our HostDxￃﾢ￢ﾀﾞￂﾢ tests report clinically actionable information on theￃﾂￂﾠpresence, type (bacterial or viral), and severity of infection in all patients. They have been extensively validated and published in top-tier medical journals. After this initial product, Inflammatix plans to develop and commercialize additional novel diagnostic tests to address significant unmet clinical needs.